GlassScriptPhysician profile
Reginald A Allen
NPI 1306842240
$3,512.01
in general payments reported to CMS, 2019-2025
24 companies · $1,055 in 2025
The $1,055 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2021: $102 · 2022: $1,017 · 2023: $505 · 2024: $639 · 2025: $1,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,960 · Education: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,959.98 |
| Education | $238.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $778.32 | 2022-2024 | Urolift |
| Astellas Pharma US INC | $398.39 | 2019-2025 | Xtandi |
| Pfizer INC. | $321.63 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $300.31 | 2022-2024 | Xiaflex |
| Boston Scientific Corporation | $194.66 | 2023-2025 | Spaceoar Vue System - 10ml |
| Endo USA, INC. | $191.49 | 2024-2025 | Xiaflex |
| Ferring Pharmaceuticals INC. | $164.48 | 2019-2024 | Adstiladrin |
| Tempus Ai, INC | $159.28 | 2025 | Xt Cdx |
| Procept Biorobotics Corporation | $155.94 | 2025 | |
| Seagen INC. | $139.98 | 2025 | |
| Cook Medical LLC | $120.16 | 2019 | |
| Dendreon Pharmaceuticals LLC | $91.76 | 2025 | Provenge |
| Merck Sharp & Dohme LLC | $76.42 | 2022-2023 | Lynparza, Keytruda |
| Janssen Biotech, INC. | $75.83 | 2022-2024 | Erleada |
| Sumitomo Pharma America, INC. | $61.38 | 2025 | Orgovyx |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $50.69 | 2024-2025 | |
| Antares Pharma, INC. | $50.37 | 2022-2023 | Xyosted, Tlando, Nocdurna |
| Dentsply Ih Ab | $42.44 | 2025 | Lofric |
| Bayer Healthcare Pharmaceuticals INC. | $42.07 | 2022-2025 | |
| Laborie Medical Technologies Corp. | $24.93 | 2023 | |
| Progenics Pharmaceuticals, INC. | $20.23 | 2023 | Pylarify |
| Immunitybio, INC. | $19.77 | 2025 | |
| Halozyme INC | $16.76 | 2023 | |
| Verity Pharmaceuticals INC. | $14.72 | 2024 | Trelstar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reginald Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.